Biolife stock.

Find the latest BioLife Sciences Inc. (BLFE) stock quote, history, news and other vital information to help you with your stock trading and investing.Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to …Biolife Keto Gummies helps in boosting your immunity and digestion power and makes you becomes healthy and fit in short period of time. Thursday, Nov 30, 2023 LoginThe BioLife Solutions stock price fell by -6.21% on the last day (Wednesday, 18th Oct 2023) from $12.39 to $11.62. During the last trading day the stock fluctuated 5.35% from a day low at $11.59 to a day high of $12.21. The price has fallen in 5 of the last 10 days and is down by -14.5% for this period. Volume fell on the last day along with ...BOTHELL, Wash., April 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an …

Get the latest BioLife Sciences Inc. (BLFE) stock news and headlines to help you in your trading and investing decisions. Biolife Sciences Inc (BLFE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Biolife Solutions Inc (NASDAQ:BLFS) has a beta value of 1.60 and has seen 2.24 million shares traded in the last trading session. The company, currently valued at $596.91M, closed the last trade at $13.25 per share which meant it gained $0.88 on the day or 7.11% during that session. The BLFS stock ...

Complete BioLife Sciences Inc. stock information by Barron's. View real-time BLFE stock price and news, along with industry-best analysis.Open 18.44. Day High 18.95. Day Low 18.17. Prev Close 18.25. 52 Week High 26.96. 52 Week High Date 09/08/22. 52 Week Low 10.40. 52 Week Low Date 05/12/22. Market Cap 812.385M.Web

BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ...Roderick de Greef appointed Chairman and Chief Executive Officer bringing 20+ years of prior BioLife experience. Garrie Richardson appointed Chief Revenue Officer. Preliminary Q3 revenue of $33.3 million and expect 2023 revenue at the low end of the previously announced guidance range . BOTHELL, Wash., Oct. 19, 2023 /PRNewswire/ - …WebAs follows, BioLife procured $29.2M compared to $10.8M for the same period a year prior. As such, this represents a 200% year-over-year (YOY) growth. Of the total revenue, the bulk comes from ...BLFS: Raising target price to $11.00BIOLIFE SOLUTIONS INC has an Investment Rating of SELL; a target price of $11.000000; an Industry Subrating of Low; a Management …Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...

See the latest Biolife Sciences Inc stock price (BLFE:PINX), related news, valuation, dividends and more to help you make your investing decisions.

Nov 8, 2023 · Biolife Solutions releases figures for Q3 on November 9. Wall Street analysts predict losses per share of $0.364. Go here to track Biolife Solutions stock price in real-time ahead of earnings.

BANNOCKBURN, Ill., March 27, 2023--BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of its 200th plasma donation center in the United ...BLFE | Complete BioLife Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to ...The estimated net worth of Roderick de Greef is at least $463,582.14 as of November 30th, 2022. Mr. de Greef owns 34,314 shares of BioLife Solutions stock worth more than $463,582 as of November 20th. This net worth estimate does not reflect any other investments that Mr. de Greef may own.WebStock gifts should include both the number of stocks given and the stock name. It should not include the fair market value of the stock. Donations of cryptocurrency should include the amount donated and the type of currency. For gifts of property, the physical address/location should be marked on the letter so the IRS can match it with any ...

BioLife Solutions (BLFS) (Delayed Data from NSDQ) $13.57 USD -0.06 (-0.44%) Updated Nov 22, 2023 03:59 PM ET After-Market: $13.55 -0.02 (-0.15%) 7:20 PM ET Add to portfolio Zacks Rank: 3-Hold 3...BioLife Solutions Return On Equity is currently at (0.23)%. Return on Equity or ROE tells BioLife Solutions stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing BioLife Solutions profitability or the management effectiveness given the capital invested by the shareholders. ROE shows …Apr 18, 2022 · Cryoport ( CYRX) is one such company that delivered phenomenal results. BioLife Solutions, Inc. ( NASDAQ: BLFS) is the other leading company in this niche. In the past few months, BioLife was hit ... Open 18.44. Day High 18.95. Day Low 18.17. Prev Close 18.25. 52 Week High 26.96. 52 Week High Date 09/08/22. 52 Week Low 10.40. 52 Week Low Date 05/12/22. Market Cap 812.385M.WebNotes to Financial Statements Business Combination Disclosure [Text Block] 3. Acquisitions Sexton acquisition General terms and effects On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation (“Sexton Merger Sub”), Fortis Advisors LLC, in its capacity …Nov 29, 2023 · BioLife was founded as Trans Time Medical Products in 1987 and went public in 1989, raising net proceeds of $4.6 million at $105 per share (after giving effect to 1-for-five (2000) and 1-for-14 ... Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to …

Stock gifts should include both the number of stocks given and the stock name. It should not include the fair market value of the stock. Donations of cryptocurrency should include the amount donated and the type of currency. For gifts of property, the physical address/location should be marked on the letter so the IRS can match it with any ...

Notes to Financial Statements Business Combination Disclosure [Text Block] 15. Acquisitions Sexton acquisition General terms and effects On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation (“Sexton Merger Sub”), Fortis Advisors LLC, in …BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.biolife sciences inc. biolife sciences inc. 0.00 ‎-11.11% 0.0004 Macquarie Group Ltd. now owns a total of 68,317 shares of BioLife Solutions’ stock after purchasing an additional 12,644 shares during the period. At the end of the most recent quarter, Macquarie Group Ltd.’s stake in BioLife Solutions was valued at approximately $1,486,000. This amounted to 0.16% ownership of the medical equipment provider ...B. Riley FBR analyst Marc Wiesenberger resumed coverage of BioLife stock with a Buy rating and a price target of $27 per share, representing a 94.6% premium to Thursday's closing price. As cell ...WebNov 30, 2023 · See the latest BioLife Solutions Inc stock price (BLFS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Stock analysis for Biolife Sciences Inc (BLFE:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

22 มี.ค. 2564 ... BioLife expects the acquisition of Stirling to impact the Company's financial performance as follows: 2021 revenue contribution is expected to ...

BioLife Solutions Trading Up 2.5 %. NASDAQ BLFS traded up $0.33 on Monday, hitting $13.58. 44,504 shares of the stock were exchanged, compared to its average volume of 403,529. The company’s 50 ...BioLife Solutions, Inc. (NasdaqCM:BLFS) entered into a definitive agreement and plan of merger to acquire Global Cooling, Inc. for approximately $270 million on March 19, 2021. Under the terms of the transaction, BioLife will issue 6.65 million shares of its common stock. The consideration also include the assumption of $8.7 million debt.WebBioLife was founded as Trans Time Medical Products in 1987 and went public in 1989, raising net proceeds of $4.6 million at $105 per share (after giving effect to 1-for-five (2000) and 1-for-14 ...Biolife Solutions releases figures for Q3 on November 9. Wall Street analysts predict losses per share of $0.364. Go here to track Biolife Solutions stock price in real-time ahead of earnings.Nov 8, 2023 · Biolife Solutions releases figures for Q3 on November 9. Wall Street analysts predict losses per share of $0.364. Go here to track Biolife Solutions stock price in real-time ahead of earnings. Biolife Solutions stocks price quote with latest real-time prices, charts, financials, latest news, ... Do the numbers hold clues to what lies ahead for the stock? BLFS: 20.37 ( …Dec 4, 2023 · Rhumbline Advisers decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 8.1% in the second quarter, Holdings Channel.com reports. The institutional investor owned 80,251 shares of the medical equipment provider’s stock after selling 7,097 shares during the period. Rhumbline Advisers’ holdings in BioLife Solutions were worth $1,774,000 as of its most recent […] If you’re looking to donate plasma, Biolife Plasma Centers are a fantastic option. They offer convenient locations, a streamlined donation process, and compensation for your time. In this comprehensive guide, we’ll cover everything you need...Mar 23, 2023 · Broadridge Corporate Issuer Solutions, Inc. P.O. Box 1342 Brentwood, New York 11717 USA (877) 830 - 4936 [email protected]

Aug 9, 2021 · BOTHELL, Wash., Aug. 9, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has entered into a definitive agreement to acquire all remaining outstanding shares of privately held Sexton ... BIOLIFE : B Riley Raises BioLife Solutions' PT to $61 from $35.50 After Q4 Revenue Beats Street, Announces Stirling Ultracold Deal; Keeps Buy Rating 2021: MT BIOLIFE : Maxim Adjusts Price Target on BioLife Solutions to $60 From $40, Maintains Buy Rating 2021: MTAccording to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.Instagram:https://instagram. stocks vmwaretastytrade day trade counteronzoombumbo changing pad vs keekaroo Stock analysis for BioLife Solutions Inc (BLFS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. rpg etfchicony electronics Beta 0.53. Rev. per Employee $608.79K. P/E Ratio 31.69. EPS $0.44. Yield 3.96%. Dividend $0.31. Ex-Dividend Date Mar 30, 2023. Short Interest 8.71M 10/31/23. % of Float Shorted 0.28%. vanguard total international stock index fund etf BioLife Solutions, Inc. announced that it has received $10.374976 million in funding from Casdin Capital, LLC. 10-19. CI. Lake Street Adjusts Price Target on BioLife Solutions to $25 From $34, Maintains Buy Rating. 08-09. MT. Transcript : BioLife Solutions, Inc., Q2 2023 Earnings Call, Aug 08, 2023. 08-09.WebIf you’re looking to donate plasma, Biolife Plasma Centers are a fantastic option. They offer convenient locations, a streamlined donation process, and compensation for your time. In this comprehensive guide, we’ll cover everything you need...Aug 9, 2023 · What really drove the stock down was BioLife's guidance. Management now expects yearly revenue to be between $144 million and $158 million, meaning a drop of between 2% and 11% over 2022.